Printer Friendly

Articles from M2 Pharma (November 17, 2014)

1-13 out of 13 article(s)
Title Author Type Words
Edwards Lifesciences names new director. 102
Genzyme wins US FDA approval for Lemtrada for the treatment of relapsing forms of multiple sclerosis. 267
GlaxoSmithKline seeks proposals for Africa non-communicable diseases Open Lab. 142
Information & Insights introduces UL ClearView. 102
NewLink Genetics elects Dr Thomas P. Monath as chief scientific officer and chief operations officer of its Infectious Disease Division. 156
Novartis Pharmaceuticals announces results from Phase III FUTURE 1 and FUTURE 2 studies of AIN457. 168
Protagen, Qiagen to co-develop protein-based companion diagnostics for autoimmune disorders. 299
Sequenta, Illumina to co-market IVD kit for NGS-based minimal residual disease detection. 206
Sinovac Biotech reports unaudited financial results for January to September 2014. Financial report 111
Study indicates Nedd4-1 is exceptional prognostic biomarker for GCA, functionally associated with metastasis. 220
Thermo Fisher introduces new digital PCR application capable of identifying drug metabolising phenotypes. 326
University at Buffalo researchers receive patent for Sjogren's syndrome test. 586
Valeant buys Nicox's US ophthalmic diagnostics unit for up to USD 20m. 323

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters